| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/13/2000 | WO1999038501A3 Method of regulating glucose metabolism, and reagents related thereto |
| 01/13/2000 | WO1999018941A3 Ih-MODULATORS |
| 01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | DE19830201A1 Mittel mit antidepressiver Wirkung Agent with an antidepressant activity |
| 01/13/2000 | CA2356841A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2345919A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | CA2337794A1 Transgene expression in polarized cells |
| 01/13/2000 | CA2336894A1 New benzoxazoles with pde-inhibiting activity |
| 01/13/2000 | CA2336774A1 Angiogenesis inhibitors |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336419A1 Novel indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2335967A1 Process for producing (8- chloro-3,10- dibromo-6,11- dihydro- 5h-benzo ¬5,6|cyclohepta ¬1,2-b|pyridin-11-yl)- 1-piperidine |
| 01/13/2000 | CA2335918A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | CA2333307A1 Compositions and methods for in vitro fertilization |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | CA2276765A1 Disposable monomer dispenser and vial breaker |
| 01/12/2000 | EP0970955A1 Paroxetine methanesulfonate |
| 01/12/2000 | EP0970954A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970698A1 Use of D-galactose for preventing necrosis |
| 01/12/2000 | EP0970695A1 Methods for increasing levels of acetylcholine |
| 01/12/2000 | EP0970694A2 Use of carprofen and derivatives therof for treating or preventing articular degeneration |
| 01/12/2000 | EP0970693A1 Biologically active labdane or labdene derivatives from Cistus |
| 01/12/2000 | EP0970379A1 Methods to identify beta-amyloid reducing agents |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970195A1 Fatty-acid amide hydrolase |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970120A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 01/12/2000 | EP0970116A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970105A1 Process for preparing carboxamido-4-azasteroids |
| 01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |
| 01/12/2000 | EP0970090A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 01/12/2000 | EP0970089A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 01/12/2000 | EP0970088A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 01/12/2000 | EP0970084A1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 01/12/2000 | EP0970083A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 01/12/2000 | EP0970081A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders |
| 01/12/2000 | EP0970076A1 7-[(piperidin-1-yl)- propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 01/12/2000 | EP0970073A1 Process for preparing eprosartan |
| 01/12/2000 | EP0970070A1 Phthalazines with angiogenesis inhibiting activity |
| 01/12/2000 | EP0970067A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
| 01/12/2000 | EP0970062A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/12/2000 | EP0970060A1 Lta 4 hydrolase inhibitors |
| 01/12/2000 | EP0970056A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 01/12/2000 | EP0970053A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 01/12/2000 | EP0969866A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969859A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf) |
| 01/12/2000 | EP0969849A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate |
| 01/12/2000 | EP0969842A1 Pharmaceutical composition |
| 01/12/2000 | EP0969840A1 Thrombin inhibitors |
| 01/12/2000 | EP0969836A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/12/2000 | EP0969835A1 Use of central cannabinoid receptor antagonists for regulating appetence |
| 01/12/2000 | EP0969834A1 Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent |
| 01/12/2000 | EP0969833A1 Extension of the expression of transgenic proteins by immunomodulation |
| 01/12/2000 | EP0969832A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/12/2000 | EP0969830A1 Drugs for memory enhancement |
| 01/12/2000 | EP0969828A1 Butyrate prodrugs derived from lactic acid |
| 01/12/2000 | EP0969824A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis |
| 01/12/2000 | EP0969817A1 Dosage forms having improved release properties |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/12/2000 | EP0969737A1 Pet food composition |
| 01/12/2000 | EP0941224A4 Multivalent salts of pyridostigmine and related compounds |
| 01/12/2000 | EP0862566B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/12/2000 | EP0808307B1 Bicyclic isothiourea derivatives useful in therapy |
| 01/12/2000 | EP0714390B1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
| 01/12/2000 | EP0640081B1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht4 antagonists |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | CN1241192A Pro-drugs and counterparts of camptothecin, their application as medicines |
| 01/12/2000 | CN1241185A Heterocyclic substed. pyrrolidine amide derivs. |
| 01/12/2000 | CN1241181A Pharmaceutical compounds |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240646A Injectable composition of non-steroidal anti-inflammatory drugs |
| 01/12/2000 | CN1048247C Neuroprotective chroman compounds |
| 01/12/2000 | CN1048245C 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivs., their preparing process and anti-ulcer composition contg. same |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
| 01/11/2000 | US6013809 Analgesics |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013780 VEGF145 expression vectors |
| 01/11/2000 | US6013675 Therapeutic substituted guanidines |
| 01/11/2000 | US6013674 Indenone amide derivatives, useful for for the inhibition of leukocyte adherence to endothelial cells; useful in the treatment of inflammatory diseases, as arthritis, asthama, psoriasis, respiratory distress syndrome, stroke and ulcer |
| 01/11/2000 | US6013672 Administering to an individual suffering from head, spinal cord trauma, stroke and epilepsy a therapeutically effective dose of a metabotropic glutamate receptor agonist |
| 01/11/2000 | US6013658 Animal growth regulators |
| 01/11/2000 | US6013656 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors |